https://www.thebodypro.com/article/updates-for-prezista-darunavir-for-use-in-pregnant
Darunavir (Prezista)News

Updates for Prezista (Darunavir) for Use in Pregnant Women

    Figure 1
    Figure 1: Pharmacokinetic Results (Within-Subject Comparison) of Total and Unbound Darunavir After Administration of Prezista/Ritonavir at 600/100 mg Twice Daily or 800/100 mg Once Daily as Part of an Antiretroviral Regimen, During the 2nd and 3rd Trimester of Pregnancy Compared to Postpartum
    U.S. Food and Drug Administration
    U.S. Food and Drug Administration

    U.S. Food and Drug Administration